Clinical Trial

HIBA-Institutional Registry of Amyloidosis

Study acronym: RIA-HIBA
Completed
View on ClinicalTrials.gov →
Summary
1. Creating a population-based registry system Amyloidosis prospective epidemiological survey * risk factors * diagnosis * prognosis * treatment * monitoring * survival 2. Describe the occurrence of amyloidosis in the population of HIBA, Hospital Italiano de Buenos Aires. 3. Describe the characteristics of clinical presentation, evolution and predisposing factors of amyloidosis.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-22
notable Primary completion moved earlier: 2030-01 -> 2026-07 2026-07-22
minor Completion moved earlier: 2030-01 -> 2026-07 2026-07-22
Trial Details
NCT Number NCT01347047
Lead Sponsor Hospital Italiano de Buenos Aires
Collaborators: Instituto Cardiovascular de Buenos Aires, Austral University, Argentina, Hospital de Alta Complejidad en Red, Hospital de Clinicas José de San Martín, HOSPITAL BRITANICO DE BUENOS AIRES, Hospital Privado de Rosario, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno, La Fundacion Favaloro para la Investigacion y la Docencia Medica, Sanatorio Anchorena, Centro Médico Uruguayo, Uruguay, Clínica Foianini, Bolivia
Conditions Amyloidosis
Enrollment 500 participants
Start Date 2011-04
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-21